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Figure S1. Expression of hypertrophic genes in the mouse hearts in response to TAC. 
Relative expression of mRNA to 18s RNA (internal control) was quantified by qPCR with 
mouse left ventricle lysates at indicated time after TAC surgery. The increase in Myh7 and 
decrease in Myh6 indicate cardiac hypertrophy. The number of animals examined: Baseline 
n=6, Day 3 n=4, Day 7 n=5 and Day 14 n=6. Data were shown as mean ± SEM. Compared 





Figure S2. Exons 21+22 inclusion level in left ventricles of human patients with or 
without dilated or ischemic cardiomyopathy. Inclusion level of exons 21+22 was 
significantly higher in heart tissues from patients with dilated cardiomyopathy (DCM, 2.84%) 
than that in control heart tissue (1.04%). No elevation of inclusion level of exons 21+22 was 
observed in heart samples from patients with ischemic cardiomyopathy (ICM, 0.78%). The 
number of human samples examined: Ctrl, n=6; DCM, n=11; ICM, n=8. Data were shown as 





Table S1. Patient characteristics for human heart samples 
 
Group	   Sample	  
code	  





2634	   53	   M	   	   SAH	   	  
2824	   48	   M	   	   ICB	   	  
2871	   NA	   NA	   	   	   	  
3074	   47	   M	   	   Intraventricular 
haemorrhage 
	  
7454	   NA	   NA	   	   	   	  
Clontech	   Cat#	  
636532	  
Normal	  human	  heart	  total	  RNA	  
DCM	  
TB12.0122 61	   M	   26/01/2012	   Non-ischemic 
cardiomyopathy 
- diagnosed 
1997 (with LV 



























since about Nov 
11. 
Decompensated 
CCF / admitted 
Nov 11. LVDD 
64mm / EF 
<25% (echo) 

























Carvedilol  Thyroxine  
Allopurinol  
Amiodarone 
TB12.0754 43	   M	   31/05/12	   Dilated 
Cardiomyopathy 














was transferred from 
another hospital and 
notes were not 
available to collect 
information. 
TB11.1027 64	   F	   25/08/11	   Dilated 
Cardiomyopathy	  
NA	  
TB12.1094 29	   M	   30/07/12	   Dilated 
Cardiomyopathy 



































































TB12.0858 50	   M	   20/06/12	   NA	   NA	  










TB12.1253 52	   M	   23/08/12	   ORIF # wrist 
1983; MI 2002; 





































TB12.1375 60	   M	   14/09/12	   ICD in situ, Drug 
eluting stents, 
















VT on Holter, 
series of MI, 
CABG 2005, 
Bumetanide, 
Epleronone, 
Ramipril, Bisoprolol, 
Lansoprazole, 
Prosigrel, Aspirin, 
Simvastatin, 
Amiodarone, 
Nitrazepam 
	  
 
 
 
